Health Enterprise Partners

Type

Private equity

Status

Active

Location

New York, United States

Total investments

38

Average round size

25M

Portfolio companies

27

Rounds per year

2.24

Lead investments

9

Follow on index

0.29

Exits

10

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
SoftwareAnalyticsInformation TechnologyFitnessHealth CareHospitalWellnessMedicalPharmaceuticalTherapeutics

Summary

Health Enterprise Partners is the famous VC, which was founded in 2006. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the New York.

Among the various public portfolio startups of the fund, we may underline Evariant, Sapphire Digital, MobileMD The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Knowledge Management, Wellness.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Health Enterprise Partners, startups are often financed by Square 1 Bank, Rock Health, Lightspeed Venture Partners. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, McKesson Ventures, Goldman Sachs. In the next rounds fund is usually obtained by McKesson Ventures, Goldman Sachs, Salesforce Ventures.

The current fund was established by Christopher Gregoire, Mathieu Gagnon.

Opposing the other organizations, this Health Enterprise Partners works on 10 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019. Considering the real fund results, this VC is 22 percentage points more often commits exit comparing to other organizations.

Show more

Investor highlights

Industry focus
HealthcareMedtechBiotech/Life Sciences

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
38
Lead investments
9
Exits
10
Rounds per year
2.24
Follow on index
0.29
Investments by industry
  • Health Care (37)
  • Wellness (10)
  • Medical (9)
  • Information Technology (6)
  • Software (6)
  • Show 34 more
Investments by region
  • United States (38)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
17M
Group Appearance index
0.79
Avg. company exit year
9
Avg. multiplicator
1.64
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Evariant 23 Nov 2015 Health Care, Medical Late Stage Venture 42M United States, Connecticut
NOCD 31 Jan 2023 Health Care, Wellness, Therapeutics Early Stage Venture 34M United States, Illinois, Chicago

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.